164 related articles for article (PubMed ID: 30374014)
1. Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro.
Liu M; Wang Z; Liu Q; Zhu H; Xu N
Med Sci Monit; 2018 Oct; 24():7750-7758. PubMed ID: 30374014
[TBL] [Abstract][Full Text] [Related]
2. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
[TBL] [Abstract][Full Text] [Related]
3. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.
Shi M; Du L; Liu D; Qian L; Hu M; Yu M; Yang Z; Zhao M; Chen C; Guo L; Wang L; Song L; Ma Y; Guo N
J Pathol; 2012 Oct; 228(2):148-57. PubMed ID: 22287315
[TBL] [Abstract][Full Text] [Related]
5. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
7. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
9. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
Song L; Liu S; Zeng S; Zhang L; Li X
Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.
Veena MS; Raychaudhuri S; Basak SK; Venkatesan N; Kumar P; Biswas R; Chakrabarti R; Lu J; Su T; Gallagher-Jones M; Morselli M; Fu H; Pellegrini M; Goldstein T; Aladjem MI; Rettig MB; Wilczynski SP; Shin DS; Srivatsan ES
J Biol Chem; 2020 Dec; 295(50):17169-17186. PubMed ID: 33028635
[TBL] [Abstract][Full Text] [Related]
11. [miR-143 inhibits cell proliferation through targeted regulating the expression of K-ras gene in HeLa cells].
Qin HX; Cui HK; Pan Y; Hu RL; Zhu LH; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):893-897. PubMed ID: 27998464
[No Abstract] [Full Text] [Related]
12. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.
Wang LQ; Zhang Y; Yan H; Liu KJ; Zhang S
Biochem Biophys Res Commun; 2015 Apr; 459(3):515-20. PubMed ID: 25747718
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1.
Xu Y; Zhao S; Cui M; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):10294-304. PubMed ID: 26617737
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 regulates the viability and invasion of cervical cancer cells.
Lin C; Huang F; Shen G; Yiming A
Int J Clin Exp Pathol; 2015; 8(9):10148-55. PubMed ID: 26617722
[TBL] [Abstract][Full Text] [Related]
17. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
18. The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells.
Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
Cell Physiol Biochem; 2017; 44(5):1882-1895. PubMed ID: 29224019
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-197 influences 5-fluorouracil resistance via thymidylate synthase in colorectal cancer.
Sun Z; Zhou N; Han Q; Zhao L; Bai C; Chen Y; Zhou J; Zhao RC
Clin Transl Oncol; 2015 Nov; 17(11):876-83. PubMed ID: 26055341
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
